Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04746794 · ClinicalTrials.gov registry record · NA

Early Detection of GEnetic Risk (EDGE)

A NA study of Genetic Predisposition, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
20,184
Enrollment target
2
Study locations

NCT04746794 is a NA study of Genetic Predisposition that has completed, run by University of Washington. The registered enrollment target is 20,184 participants, above the 2,078-participant average among 14 other Genetic Predisposition trials with a reported enrollment target (871% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04746794, a NA study of Genetic Predisposition, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
20,184 participants
Enrollment target
2
Study locations

Study Summary

The study intervention involves having patients complete a familial cancer risk assessment survey. Those who are found to be at high risk will be offered genetic testing for a panel of hereditary cancers. A "previvor" plan will be created to assist patients and their providers in completing the appropriate follow-up for those with a mutation identified.

Conditions Studied

Genetic Predisposition

Interventions

  • BEHAVIORAL Population-level screening

Study Locations (2)

Montana

  • Billings Clinic - Billings

Washington

  • MultiCare Health System - Tacoma

Trial Details

FieldValue
Enrollment Target 20,184 participants
Start Date 2020-09-25
Est. Completion 2023-06-01
Phase NA

Sponsor

University of Washington

1,048 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04746794

The ClinicalTrials.gov registry entry for NCT04746794 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20,184 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,078-participant average among 14 other Genetic Predisposition trials with a reported enrollment target (871% higher). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Genetic Predisposition appearing as the primary indexed condition, and to 1 intervention - of which Population-level screening is the first listed.

NCT04746794 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Montana, Washington.

Frequently Asked Questions

What is clinical trial NCT04746794 about?

NCT04746794 is a clinical study titled "Early Detection of GEnetic Risk (EDGE)". The study intervention involves having patients complete a familial cancer risk assessment survey. Those who are found to be at high risk will be offered genetic testing for a panel of hereditary cancers. A "previvor" plan will be created to assist patients and their providers in completing the appr...

What is the current status of trial NCT04746794?

This trial is currently completed. It is a NA study. The enrollment target is 20,184 participants. The study started on 2020-09-25. Estimated completion is 2023-06-01.

What conditions does trial NCT04746794 study?

This clinical trial studies the following conditions: Genetic Predisposition.

What interventions are being tested in trial NCT04746794?

The interventions under investigation include: Population-level screening (BEHAVIORAL).

Who is sponsoring clinical trial NCT04746794?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04746794 being conducted?

This trial has 2 study locations across Montana, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Genetic Predisposition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Genetic Predisposition

All registered trials for this condition

Montana

All trials with a study site in Montana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.